NCT02751385View on ClinicalTrials.gov

Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer

PHASE1TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

May 20, 2016

Primary Completion Date

November 28, 2017

Study Completion Date

November 28, 2017

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

Microgynon

DRUG

Nintedanib

Trial Locations (1)

09116

Klinikum Chemnitz gGmbH, Chemnitz

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02751385 - Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter